Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more
Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Total Assets
Latest total assets as of June 2025: ILA7.83 Million ILA
Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) holds total assets worth ILA7.83 Million ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tikun Olam Cannbit Pharmaceuticals Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tikun Olam Cannbit Pharmaceuticals Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Tikun Olam Cannbit Pharmaceuticals Ltd's total assets of ILA7.83 Million consist of 27.0% current assets and 73.0% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0.7% |
| Accounts Receivable | ILA3.92 Million | 16.3% |
| Inventory | ILA1.26 Million | 5.3% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA9.81 Million | 40.9% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tikun Olam Cannbit Pharmaceuticals Ltd's current assets represent 27.0% of total assets in 2024, a decrease from 704.2% in 2017.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2024, down from 51.7% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 40.9% of total assets.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Total Assets
Key competitors of Tikun Olam Cannbit Pharmaceuticals Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Tikun Olam Cannbit Pharmaceuticals Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Tikun Olam Cannbit Pharmaceuticals Ltd generates 1.46x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tikun Olam Cannbit Pharmaceuticals Ltd is currently not profitable relative to its asset base.
Tikun Olam Cannbit Pharmaceuticals Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.20 | 0.60 | 2.54 |
| Quick Ratio | 0.17 | 0.48 | 1.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-16.35 Million | ILA -10.33 Million | ILA 28.01 Million |
Tikun Olam Cannbit Pharmaceuticals Ltd - Advanced Valuation Insights
This section examines the relationship between Tikun Olam Cannbit Pharmaceuticals Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.63 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -68.6% |
| Total Assets | ILA24.01 Million |
| Market Capitalization | $75.63K USD |
Valuation Analysis
Below Book Valuation: The market values Tikun Olam Cannbit Pharmaceuticals Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tikun Olam Cannbit Pharmaceuticals Ltd's assets decreased by 68.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual total assets of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA24.01 Million | -68.65% |
| 2023-12-31 | ILA76.57 Million | -51.17% |
| 2022-12-31 | ILA156.82 Million | -17.36% |
| 2021-12-31 | ILA189.78 Million | -2.58% |
| 2020-12-31 | ILA194.81 Million | +25.34% |
| 2019-12-31 | ILA155.43 Million | +2084.16% |
| 2018-12-31 | ILA7.12 Million | +5930.51% |
| 2017-12-31 | ILA118.00K | -- |